Myriad Genetics (MYGN) Free Cash Flow Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 23.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 14.16% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 30.41% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.52% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 28.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.07% |
| Dec 31, 2025 | 31.41% |
| Sep 30, 2025 | 35.06% |
| Jun 30, 2025 | 48.73% |
| Mar 31, 2025 | 25.77% |
| Dec 31, 2024 | 30.70% |
| Sep 30, 2024 | 62.04% |
| Mar 31, 2024 | -31.70% |
| Dec 31, 2023 | 16.50% |
| Sep 30, 2023 | 22.01% |
| Jun 30, 2023 | -18.34% |
| Mar 31, 2023 | -82.80% |
| Dec 31, 2022 | -43.59% |
| Sep 30, 2022 | -48.84% |
| Jun 30, 2022 | -51.21% |
| Mar 31, 2022 | -157.56% |
| Dec 31, 2021 | -33.30% |
| Sep 30, 2021 | -114.56% |
| Mar 31, 2021 | 95.95% |
| Dec 31, 2020 | -66.80% |